Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Paradigm Clinical Research - Redding, California

Verified

Basic Information

Site Overview

Source: Human-provided.

Paradigm Clinical Research opened its first site in 2009 in Redding, California. Today, Paradigm operates a growing roster of wholly-owned research sites that provide our clients access to diverse and often under-represented patient populations and investigators. We are uniquely positioned to deliver superior value by continuously lowering barriers to study participation for study volunteers and investigators.We partner with principal investigators in a wide variety of medical specialties to execute both healthy volunteer and patient studies. You can rely on our deep expertise and track record of successfully achieving our enrollment goals.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Building

Business Subcategory

Source: Google. Building
Source: Trial-derived.
10Total Trials
Source: Trial-derived.
3Recruiting Trials
Source: Trial-derived.
6Active Trials
Source: Trial-derived.
4Completed Trials
Source: Trial-derived.
20Unique Conditions
Source: Trial-derived.
20Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Interstitial Lung Disease (2)Source: Trial-derived. Progressive Pulmonary Fibrosis (2)Source: Trial-derived. Acute Gastroenteritis (1)Source: Trial-derived. Bronchiectasis (1)Source: Trial-derived. Chronic Obstructive Pulmonary Disease (1)Source: Trial-derived. Coronavirus (1)Source: Trial-derived. Covid19 (1)Source: Trial-derived. COVID-19 SARS-CoV-2 Infection (1)

Sponsors

Source: Trial-derived. ModernaTX, Inc. (2)Source: Trial-derived. Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1)Source: Trial-derived. AstraZeneca (1)Source: Trial-derived. Avalyn Pharma Inc. (1)Source: Trial-derived. bioRASI, LLC (1)Source: Trial-derived. Boehringer Ingelheim (1)Source: Trial-derived. Brii Biosciences Limited (1)Source: Trial-derived. Bristol-Myers Squibb (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Spirometry
Source: AI-inferred. CT Scan
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. Sequencing / genomics

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic participant diary (ePRO) system
Source: AI-inferred. Electronic patient-reported outcome collection
Source: AI-inferred. Hemagglutination inhibition (HAI) assay
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay
Source: AI-inferred. Nebulised inhaled study drug administration
Source: AI-inferred. Pulse oximetry